Loading company…
Onepot AI provides a secure platform for AI-enabled small molecule design and synthesis.
Onepot AI develops an AI-enabled small molecule synthesis platform that encrypts molecular structures for secure handling. It serves pharmaceutical and biotechnology researchers working on drug discovery. Founded in 2025, the company is based in South San Francisco, US, and raised an undisclosed amount of pre-seed funding as part of a larger USD 13 mn round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in